tradingkey.logo

SI-BONE Inc

SIBN
View Detailed Chart
15.770USD
+0.580+3.82%
Close 11/07, 16:00ETQuotes delayed by 15 min
678.33MMarket Cap
LossP/E TTM

SI-BONE Inc

15.770
+0.580+3.82%
Intraday
1m
30m
1h
D
W
M
D

Today

+3.82%

5 Days

+6.34%

1 Month

+0.32%

6 Months

-14.71%

Year to Date

+12.48%

1 Year

+2.94%

View Detailed Chart

TradingKey Stock Score of SI-BONE Inc

Currency: USD Updated: 2025-11-07

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

SI-BONE Inc's Score

Industry at a Glance

Industry Ranking
33 / 209
Overall Ranking
93 / 4614
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 9 analysts
Buy
Current Rating
24.778
Target Price
+57.12%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

SI-BONE Inc Highlights

StrengthsRisks
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 57.11% year-on-year.
Undervalued
The company’s latest PE is -28.10, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 41.43M shares, decreasing 9.37% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 150.02K shares of this stock.

SI-BONE Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

SI-BONE Inc Info

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Ticker SymbolSIBN
CompanySI-BONE Inc
CEOMs. Laura A. Francis
Websitehttps://si-bone.com/
KeyAI